NorthView Acquisition Corporation NorthView Acquisition Corporation

NorthView Acquisition Corporation

NVACR

Rang in aandelen #37962
NorthView Acquisition Corporation aims to complete a business combination, such... NorthView Acquisition Corporation aims to complete a business combination, such as a merger, capital stock exchange, asset acquisition, stock purchase, or corporate reorganization, with one or more companies. The firm plans to concentrate its search for potential targets within the healthcare industry. Founded in 2021, this New York-based entity operates as a subsidiary of NorthView Sponsor I, LLC.
Aandeelprijs
$0.2301
Laatst gesynchroniseerd: 2025-07-11
Marktkapitalisatie
$1.24M
Verandering (1 dag)
35.35%
Verandering (1 jaar)
-90.80%
Land
US
Handel NorthView Acquisition Corporation (NVACR)

Categorie

Financial Services
Dividendrendementgeschiedenis voor NorthView Acquisition Corporation (NVACR)
Het dividendrendement (TTM) van NorthView Acquisition Corporation (aandelsymbool: NVACR) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van NorthView Acquisition Corporation (NVACR) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten